Breaking News, Promotions & Moves

Tagworks Appoints Ken Mills as CEO

Dr. Marc Robillard, the founding CEO of Tagworks, will continue in the role of Chief Scientific Officer and as a board member.

Author Image

By: Charlie Sternberg

Associate Editor

Tagworks Pharmaceuticals BV, a precision oncology company, has appointed Ken Mills as Chief Executive Officer and member of the Board of Directors.   As part of this planned CEO leadership transition, Marc Robillard, Ph.D., the founding CEO of Tagworks, will continue in the role of Chief Scientific Officer and as a board member.   “Ken brings a wealth of valuable experience and understanding in bringing novel treatments to patients, combined with a strong track record in company buildi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters